SCHEMBL27743575

SCHEMBL27743575

O=CC1COC[C@H]2CNCCN12

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27722873 1.00 HTR6 (0.31) HTR6
SCHEMBL28096972 0.77 HTR6 (0.37) HTR6
SCHEMBL27772815 0.76 HTR6 (0.35) HTR6
Hydrochloric Acid SCHEMBL28152915 0.74 HTR6 (0.34) HTR6
SCHEMBL27815135 0.71 HTR6 (0.44) HTR6
SCHEMBL27637870 0.71 — —
SCHEMBL16279234 0.67 HTR2C (0.32) HTR6
SCHEMBL17645128 0.67 HTR2C (0.32) HTR6
SCHEMBL20898613 0.67 HTR2C (0.32) HTR6
SCHEMBL17630240 0.67 HTR2C (0.32) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101316846-A Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia ASTRAZENECA AB (SE) 2008-12-03 — — CN claimed
CN-101316846-A Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia ASTRAZENECA AB (SE) 2008-12-03 — — CN disclosed
Send feedback